Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Murrell

Showing results (181-190 of 490) with videos related to

Pageof 49
Sort By:
European Journal of Dermatology : EJD|March 29, 2001
Guess what. Dermatofibrosarcoma protuberans presenting as an atrophic red plaqueA C See, S S Kossard, D F Murrell
Journal of the European Academy of Dermatology and Venereology : JEADV|March 4, 2020
Osteoporosis and bone health in autoimmune blistering skin disease-an evidenced based reviewM Kang, A Bilgic, M Radjenovic, et al.
JAAD International|October 17, 2022
Long-term follow-up of epidermolysis bullosa in real practice shows stability of the Epidermolysis Bullosa Disease Activity and Scarring Index and improvement with some off-label therapiesGenevieve Ho, Matthew Gibson, Nooshafarin Kazemikhoo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 6, 2015
A review of case-control studies on the risk factors for the development of autoimmune blistering diseasesD D Oh, C Y Zhao, D F Murrell
Clinics in Dermatology|July 8, 2024
Letter to the editor in reply to "A call for action: Formalin exposure and broader occupational hazards and assessing the risk of glioblastoma in clinician scientists"Hossein Akbarialiabad, Jane M Grant-Kels, Dedee F Murrell
Acta Dermatovenerologica Croatica : ADC|January 23, 2019
A Case Report of the Use of Rituximab and the Epidermolysis Bullosa Disease Activity Scoring Index (EBDASI) in a Patient with Epidermolysis Bullosa Acquisita with Extensive Esophageal InvolvementAnes Yang, Minhee Kim, Philip Craig, et al.
Dermatologic Therapy|May 28, 2020
Restructuring an academic dermatology practice during the COVID-19 pandemicTabrez Sheriff, Oliver G C Murrell, Dédée F Murrell
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|September 12, 2018
Epidermolysis Bullosa Patients' Perception of Surgical Wound and Scar HealingAdam G Harris, Samra L Saikal, Dedee F Murrell
The British Journal of Dermatology|September 10, 2016
Digenic inheritance in epidermolysis bullosa simplex involving two novel mutations in KRT5 and KRT14E Kim, A Harris, V Hyland, et al.
Clinical and Experimental Dermatology|March 13, 2022
Psoriasis and osteoporosis: a literature reviewDohyen Wi, Anna Wilson, Fanny Satgé, et al.
Pageof 49

Showing results (181-190 of 490) with videos related to

Sort By:
Pageof 49
European Journal of Dermatology : EJD|March 29, 2001
Guess what. Dermatofibrosarcoma protuberans presenting as an atrophic red plaqueA C See, S S Kossard, D F Murrell
Journal of the European Academy of Dermatology and Venereology : JEADV|March 4, 2020
Osteoporosis and bone health in autoimmune blistering skin disease-an evidenced based reviewM Kang, A Bilgic, M Radjenovic, et al.
JAAD International|October 17, 2022
Long-term follow-up of epidermolysis bullosa in real practice shows stability of the Epidermolysis Bullosa Disease Activity and Scarring Index and improvement with some off-label therapiesGenevieve Ho, Matthew Gibson, Nooshafarin Kazemikhoo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 6, 2015
A review of case-control studies on the risk factors for the development of autoimmune blistering diseasesD D Oh, C Y Zhao, D F Murrell
Clinics in Dermatology|July 8, 2024
Letter to the editor in reply to "A call for action: Formalin exposure and broader occupational hazards and assessing the risk of glioblastoma in clinician scientists"Hossein Akbarialiabad, Jane M Grant-Kels, Dedee F Murrell
Acta Dermatovenerologica Croatica : ADC|January 23, 2019
A Case Report of the Use of Rituximab and the Epidermolysis Bullosa Disease Activity Scoring Index (EBDASI) in a Patient with Epidermolysis Bullosa Acquisita with Extensive Esophageal InvolvementAnes Yang, Minhee Kim, Philip Craig, et al.
Dermatologic Therapy|May 28, 2020
Restructuring an academic dermatology practice during the COVID-19 pandemicTabrez Sheriff, Oliver G C Murrell, Dédée F Murrell
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|September 12, 2018
Epidermolysis Bullosa Patients' Perception of Surgical Wound and Scar HealingAdam G Harris, Samra L Saikal, Dedee F Murrell
The British Journal of Dermatology|September 10, 2016
Digenic inheritance in epidermolysis bullosa simplex involving two novel mutations in KRT5 and KRT14E Kim, A Harris, V Hyland, et al.
Clinical and Experimental Dermatology|March 13, 2022
Psoriasis and osteoporosis: a literature reviewDohyen Wi, Anna Wilson, Fanny Satgé, et al.
Pageof 49